Trial Profile
A Single Dose and Repeat Dose Study to Investigate the Pharmacokinetics of Ropinirole After Single and Multiple Doses of a PR-formulation in Chinese Healthy Male and Female Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Jan 2024
Price :
$35
*
At a glance
- Drugs Ropinirole (Primary)
- Indications Parkinson's disease
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline; GSK
- 22 Sep 2011 New trial record